PTCHD1: towards a molecular and cellular understanding of autism spectrum disorder

Description of the granted funding

Through this multidisciplinary project, we aim to gain fundamental insights into the cellular biology and biochemistry of PTCHD1 relevant to autism spectrum disorder (ASD), a neurodevelopmental condition characterised by eg, restricted interests and atypical social interaction. The PTCHD1 protein plays a crucial role in neurodevelopment and plasticity, and mutations in it underlie up to 1% of ASD cases. However, its biochemistry and -physics, the link between its activity and neurodevelopment, the cellular effect of mutations, and its connection to Fragile X syndrome is not understood. To gain mechanistic insight, we will determine the structure of human PTCHD1 by single particle cryo-electron microscopy. Then, to establish its function, we will study its cholesterol transport activity and investigate how the C-terminus regulates its stability and localisation to the synapse. Finally, we will follow up brand new insights suggesting how PTCHD1 is linked to Fragile X syndrome.
Show more

Starting year

2023

End year

2027

Granted funding

Adrian Goldman Orcid -palvelun logo
549 663 €

Funder

Research Council of Finland

Funding instrument

Academy projects

Other information

Funding decision number

357076

Fields of science

Biochemistry, cell and molecular biology

Research fields

Biokemia, biofysiikka

Identified topics

brain, neuroscience